While the treatment seemed safe, no significant differences in outcomes were seen between patients receiving convalescent plasma or placebo
Good Response Seen With HealthCare.gov Reopening
CMS figures show more than 206,000 people signed up for coverage from Feb. 15 to 28
Response to One Dose of COVID-19 Vaccine Strong for Previously Infected
Two studies show higher anti-S titers in those with previous infection and very strong T-cell responses
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Preliminary Data in Israel Show COVID-19 Vaccines Effectively Prevent Severe Disease
National study shows reduction in ratio of COVID-19 patients requiring mechanical ventilation aged 70 years and older to those younger than 50 years
One-Third of U.S. Adults Continue to Be Hesitant About COVID-19 Vaccines
Rates of vaccine hesitancy particularly high among Black adults and Republicans, a December survey reveals
Dramatic Decline Seen in COVID-19 Cases, Deaths at U.S. Nursing Homes
82 percent decline reported in new COVID-19 cases among residents at nursing homes since the peak during the week of Dec. 20
High Dose of Vitamin D Does Not Cut COVID-19 Hospital Stay
No significant differences seen for other outcomes among patients hospitalized with moderate-to-severe disease
COVID-19 Outcomes No Worse for People With Asthma
Patients with asthma may have a lower risk for becoming infected
J&J COVID-19 Vaccine Granted Emergency Use Authorization
The single-dose Ad26 vaccine is now the third COVID-19 vaccine to be granted an EUA